Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial-Reference-Cited by-同舟云学术

Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial

Published:2012-09 Issue:3 Volume:86 Page:238-243
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Hovanessian-Larsen Linda,Taylor DeShawn,Hawes Debra,Spicer Darcy V.,Press Michael F.,Wu Anna H.,Pike Malcolm C.,Pearce C. Leigh

Funder

University of South China

U.S. Department of Defense

USC Norris Comprehensive Cancer Center

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference33 articles.

1. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast;Hofseth;J Clin Endocrinol Metab,1999

2. An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk;Lee;Br J Cancer,2005

3. Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause;Prentice;Am J Epidemiol,2009

4. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies;Lancet,1996

5. Oral contraceptives and the risk of breast cancer;Marchbanks;N Engl J Med,2002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral contraceptives in the central nervous system: Basic pharmacology, methodological considerations, and current state of the field;Frontiers in Neuroendocrinology;2023-01

2. The progesterone-receptor modulator, ulipristal acetate, drastically lowers breast cell proliferation;Breast Cancer Research and Treatment;2022-01-11

3. Biological Effects of Green Tea Capsule Supplementation in Pre-Surgery Postmenopausal Breast Cancer Patients;Frontiers in Oncology;2013